4D pharma Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO® for the Treatment of Locally Advanced or Metastatic Urothelial CarcinomaBusiness Wire • 02/08/21
4D pharma PLC inks clinical trial collaboration and supply agreement with Merck KGaA, and Pfizer IncProactive Investors • 02/08/21
Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027Business Wire • 02/05/21
Pfizer Drops India Vaccine Application After Regulator Seeks Local Trial - ReutersBenzinga • 02/05/21
More Than One In Three People In U.K. Study Report Side Effects From Pfizer Coronavirus VaccineForbes • 02/04/21
Pfizer, Inc. (PFE) CEO Dr. Albert Bourla on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/02/21
Is Pfizer Stock A Buy On Guidance For $15 Billion In Covid Vaccine Sales?Investors Business Daily • 02/02/21
Pfizer's CEO says he sees 'no issues' in delivering 2 billion COVID-19 vaccines on time (PFE)Business Insider • 02/02/21